CO-DIAGNOSTICS INC (CODX) Stock Fundamental Analysis

NASDAQ:CODX • US1897631057

2.36 USD
-3.62 (-60.54%)
At close: Jan 13, 2026
2.4 USD
+0.04 (+1.69%)
After Hours: 1/13/2026, 8:01:56 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall CODX gets a fundamental rating of 4 out of 10. We evaluated CODX against 185 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for CODX as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, CODX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • CODX had negative earnings in the past year.
  • CODX had a negative operating cash flow in the past year.
  • In multiple years CODX reported negative net income over the last 5 years.
  • In multiple years CODX reported negative operating cash flow during the last 5 years.
CODX Yearly Net Income VS EBIT VS OCF VS FCFCODX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

  • CODX's Return On Assets of -71.93% is on the low side compared to the rest of the industry. CODX is outperformed by 73.66% of its industry peers.
  • The Return On Equity of CODX (-80.80%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -71.93%
ROE -80.8%
ROIC N/A
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
CODX Yearly ROA, ROE, ROICCODX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

  • Looking at the Gross Margin, with a value of 34.04%, CODX is doing worse than 74.73% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CODX has grown nicely.
  • The Profit Margin and Operating Margin are not available for CODX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
CODX Yearly Profit, Operating, Gross MarginsCODX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • CODX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CODX has been increased compared to 1 year ago.
  • Compared to 5 years ago, CODX has more shares outstanding
  • There is no outstanding debt for CODX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CODX Yearly Shares OutstandingCODX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CODX Yearly Total Debt VS Total AssetsCODX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • CODX has an Altman-Z score of 13.52. This indicates that CODX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CODX (13.52) is better than 92.47% of its industry peers.
  • There is no outstanding debt for CODX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.52
ROIC/WACCN/A
WACC10%
CODX Yearly LT Debt VS Equity VS FCFCODX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 3.81 indicates that CODX has no problem at all paying its short term obligations.
  • CODX has a Current ratio of 3.81. This is in the better half of the industry: CODX outperforms 66.67% of its industry peers.
  • A Quick Ratio of 3.51 indicates that CODX has no problem at all paying its short term obligations.
  • CODX has a better Quick ratio (3.51) than 70.97% of its industry peers.
Industry RankSector Rank
Current Ratio 3.81
Quick Ratio 3.51
CODX Yearly Current Assets VS Current LiabilitesCODX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The earnings per share for CODX have decreased strongly by -1416.54% in the last year.
  • Looking at the last year, CODX shows a very negative growth in Revenue. The Revenue has decreased by -93.06% in the last year.
  • CODX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 79.52% yearly.
EPS 1Y (TTM)-1416.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
Revenue 1Y (TTM)-93.06%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-77.38%

3.2 Future

  • Based on estimates for the next years, CODX will show a very strong growth in Earnings Per Share. The EPS will grow by 51.41% on average per year.
  • CODX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 101.21% yearly.
EPS Next Y-1795.58%
EPS Next 2Y-231.17%
EPS Next 3Y-121.26%
EPS Next 5Y51.41%
Revenue Next Year-88.3%
Revenue Next 2Y-62.71%
Revenue Next 3Y60.7%
Revenue Next 5Y101.21%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CODX Yearly Revenue VS EstimatesCODX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
CODX Yearly EPS VS EstimatesCODX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 20 -20

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CODX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CODX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CODX Price Earnings VS Forward Price EarningsCODX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CODX Per share dataCODX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

  • A cheap valuation may be justified as CODX's earnings are expected to decrease with -121.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-231.17%
EPS Next 3Y-121.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CODX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CO-DIAGNOSTICS INC

NASDAQ:CODX (1/13/2026, 8:01:56 PM)

After market: 2.4 +0.04 (+1.69%)

2.36

-3.62 (-60.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)03-25
Inst Owners18.52%
Inst Owner Change0.92%
Ins Owners5.87%
Ins Owner Change5.92%
Market Cap143.70M
Revenue(TTM)507.90K
Net Income(TTM)-32.18M
Analysts80
Price Target38.25 (1520.76%)
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.8%
Min EPS beat(2)1.96%
Max EPS beat(2)63.63%
EPS beat(4)3
Avg EPS beat(4)22.62%
Min EPS beat(4)-3.81%
Max EPS beat(4)63.63%
EPS beat(8)5
Avg EPS beat(8)-4.35%
EPS beat(12)7
Avg EPS beat(12)-30.05%
EPS beat(16)10
Avg EPS beat(16)-21.09%
Revenue beat(2)1
Avg Revenue beat(2)0.65%
Min Revenue beat(2)-5.23%
Max Revenue beat(2)6.54%
Revenue beat(4)1
Avg Revenue beat(4)-36.65%
Min Revenue beat(4)-86.85%
Max Revenue beat(4)6.54%
Revenue beat(8)3
Avg Revenue beat(8)53.36%
Revenue beat(12)4
Avg Revenue beat(12)112.38%
Revenue beat(16)5
Avg Revenue beat(16)77.24%
PT rev (1m)2900%
PT rev (3m)1775%
EPS NQ rev (1m)-2900%
EPS NQ rev (3m)-2780%
EPS NY rev (1m)-2900%
EPS NY rev (3m)-2681.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 282.93
P/FCF N/A
P/OCF N/A
P/B 3.61
P/tB 10.47
EV/EBITDA N/A
EPS(TTM)-19.26
EYN/A
EPS(NY)-12.39
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0.01
BVpS0.65
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -71.93%
ROE -80.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.04%
FCFM N/A
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 53.59%
Cap/Sales 126.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.81
Quick Ratio 3.51
Altman-Z 13.52
F-Score2
WACC10%
ROIC/WACCN/A
Cap/Depr(3y)92.34%
Cap/Depr(5y)204.81%
Cap/Sales(3y)14.45%
Cap/Sales(5y)9.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1416.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1400%
EPS Next Y-1795.58%
EPS Next 2Y-231.17%
EPS Next 3Y-121.26%
EPS Next 5Y51.41%
Revenue 1Y (TTM)-93.06%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-77.38%
Revenue Next Year-88.3%
Revenue Next 2Y-62.71%
Revenue Next 3Y60.7%
Revenue Next 5Y101.21%
EBIT growth 1Y11.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.26%
OCF growth 3YN/A
OCF growth 5YN/A

CO-DIAGNOSTICS INC / CODX FAQ

What is the ChartMill fundamental rating of CO-DIAGNOSTICS INC (CODX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CODX.


What is the valuation status of CO-DIAGNOSTICS INC (CODX) stock?

ChartMill assigns a valuation rating of 0 / 10 to CO-DIAGNOSTICS INC (CODX). This can be considered as Overvalued.


What is the profitability of CODX stock?

CO-DIAGNOSTICS INC (CODX) has a profitability rating of 1 / 10.


How financially healthy is CO-DIAGNOSTICS INC?

The financial health rating of CO-DIAGNOSTICS INC (CODX) is 8 / 10.